Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs StandardAero Inc. Common Stock (SARO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs StandardAero Inc. Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while StandardAero Inc. Common Stock trades at $19.73 (market cap $6.58B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Kymera Therapeutics Inc. Common Stock is trading nearer its 52-week high, StandardAero Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and StandardAero Inc. Common Stock for 0 Days on average.
| KYMR | SARO | |
|---|---|---|
Market Cap | $8.87B | $6.58B |
Volume | 779,107 | 3,663,186 |
Sector | Health | Industrials |
52-Week High | $127.31 | $33.12 |
52-Week Low | $55.80 | $19.76 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $8.96B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About StandardAero Inc. Common Stock
StandardAero, Inc. is an independent provider of aircraft engine maintenance, repair, and overhaul services, supporting commercial, military, and business aviation customers across more than 40 engine platforms.
Read more on SARO →
